MyFinsight
Home
About
Contact
inm: the income statement
Download
Download image
Net loss for the
period
-$1,726,899
(-2.92%↓ Y/Y)
Sales
$1,120,121
(-11.43%↓ Y/Y)
Loss before income
tax expense
-$1,726,899
(-2.92%↓ Y/Y)
Interest and other income
$93,765
(64.23%↑ Y/Y)
Gross profit
$403,159
(-18.29%↓ Y/Y)
Cost of sales
$716,962
(-7.04%↓ Y/Y)
Total operating
expenses
$2,223,823
(-0.20%↓ Y/Y)
Foreign exchange (gain)
loss
-$56,994
Amortization and
depreciation
$53,202
(-2.52%↓ Y/Y)
General and
administrative
$1,532,015
(7.74%↑ Y/Y)
Research and development
$581,612
(-24.58%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)